T/SBX 055-2022 Active Group standards

T/SBX 055-2022 Stem cell therapy product: Lymphoma test method

Publish Date: 2022-04-25 Implement Date: 2022-04-30 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/SBX 055-2022

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Laboratory medicine

Publish Date: 2022-04-25

Implement Date: 2022-04-30

Scope

Main technical content: This document proposes the test principles, test conditions, main reagents, instruments and equipment, and test steps for the carcinogenicity test of stem cell (including embryonic stem cells, adult stem cells, induced pluripotent stem cells, etc.) therapeutic products